(Q40814289)

24 September 2017

title

Potent inhibition of hemangiosarcoma development in mice by cidofovir (English)

1 reference

24 September 2017

3

E De Clercq

0 references

author name string

S Liekens

1

1 reference

24 September 2017

E Verbeken

2

1 reference

24 September 2017

E De Clercq

3

1 reference

24 September 2017

J Neyts

4

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

International Journal of Cancer

24 September 2017

published in

1 reference

24 September 2017

volume

92

1 reference

24 September 2017

issue

2

1 reference

24 September 2017

page(s)

161-167

1 reference

A novel selective broad-spectrum anti-DNA virus agent

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1183%3E3.0.CO%3B2-K

Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1183%3E3.0.CO%3B2-K

Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1183%3E3.0.CO%3B2-K

A New Topical Treatment for Resistant Herpes Simplex Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1183%3E3.0.CO%3B2-K

A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1183%3E3.0.CO%3B2-K

Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1183%3E3.0.CO%3B2-K

Response to cidofovir after failure of antiretroviral therapy alone in AIDS-associated progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1183%3E3.0.CO%3B2-K

(S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1183%3E3.0.CO%3B2-K

Treatment of anogenital papillomavirus infections with an acyclic nucleoside phosphonate analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1183%3E3.0.CO%3B2-K

Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1183%3E3.0.CO%3B2-K

Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1183%3E3.0.CO%3B2-K

Vascular Tumors Induced by Polyoma Virus in Pregnant Rats 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1183%3E3.0.CO%3B2-K

Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1183%3E3.0.CO%3B2-K

Mechanism of uptake of the phosphonate analog (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in Vero cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1183%3E3.0.CO%3B2-K

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1183%3E3.0.CO%3B2-K

Antitumor Potential of Acyclic Nucleoside Phosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1183%3E3.0.CO%3B2-K

In vitro sensitivity of Kaposi's sarcoma cells to various chemotherapeutic agents including acyclic nucleoside phosphonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1183%3E3.0.CO%3B2-K

J domain-independent regulation of the Rb family by polyomavirus large T antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1183%3E3.0.CO%3B2-K

Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1183%3E3.0.CO%3B2-K

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1183%3E3.0.CO%3B2-K

Insights into cancer from transgenic mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1183%3E3.0.CO%3B2-K

10.1002/1097-0215(200102)9999:9999<::AID-IJC1183>3.0.CO;2-K

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference